Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors

A significant unmet need for patients with multiple sclerosis (MS) is the lack of U.S. Food and Drug Administration (FDA)-approved remyelinating therapies. We have identified a compelling remyelinating agent, bazedoxifene (BZA), a European Medicines Agency (EMA)-approved (and FDA-approved in combina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci
Main Authors: Rankin, Kelsey A., Mei, Feng, Kim, Kicheol, Shen, Yun-An A., Mayoral, Sonia R., Desponts, Caroline, Lorrain, Daniel S., Green, Ari J., Baranzini, Sergio E., Chan, Jonah R., Bove, Riley
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6433770/
https://ncbi.nlm.nih.gov/pubmed/30696729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1530-18.2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados